Article Details
Retrieved on: 2020-12-15 14:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
TrialSpark is backed by leading investors such as Michael Moritz, John Doerr, Thrive Capital, and <b>Sequoia Capital</b>. About vTv Therapeutics
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here